I read in the paper recently(N.Z.), about new forms of pain relief being
approved by the Federal Drug Agency.
Cox 2 type, that are reported to have far less side affects.
The question to the list is,
How will this potentially effect practitioners in the musculoskeletal
field, Spinal Pain, Joint Pain etc.
My impression is that the driving force for people to consult a
practitioner, is due the pain, or what the pain may mean to the person.
Sometimes patients have seen me complaining of only lack of function,
strength etc. I.E. I cant walk on my tip toes.
With a ruptured archilles tendon on assessment.
"Had it for four weeks, hurt when I did it, but the pain went away
quickly, so I haven't bothered to get it looked at".
A patient I saw actually had it for 4 years before having someone look
at it ( this is not a representation of a normal New Zealander).
The question is, How great is the threat of substitution of product?
Cox 2 substituted for Physical Therapy.
There are probably a great deal of reasons to attend Physiotherapy, from
a clinical academic point of view.
But for the man on the street, if his major motivating reason for
seeking secondary care (physiotherapy), which in this case may be pain,
is removed or greatly diminished, will we then see far fewer people
coming through our doors looking for help?
I am interested in you're views
Kind Regards
Craig
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|